| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.81B | +35.9% |
| Cost of Revenue | $898.6M | +25.2% |
| Gross Profit | $1.91B | +41.5% |
| R&D Expense | $1.29B | +63.4% |
| SG&A Expense | $323.0M | +9.2% |
| Operating Income | -$1.09B | -30.0% |
| Pre-tax Income | -$849.2M | -4.1% |
| Income Tax | -$11.2M | +39.2% |
| Net Income | -$836.1M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.76B | +87.5% |
| Accounts Receivable | $926.9M | +29.5% |
| Current Assets | $5.04B | +1.1% |
| Total Assets | $8.22B | +6.5% |
| Current Liabilities | $2.73B | +37.0% |
| Total Liabilities | $3.03B | +34.6% |
| Stockholders' Equity | $5.18B | -5.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $848.1M | +55.4% |
| Capital Expenditures | $35.1M | +39.6% |
| Investing Cash Flow | $832.3M | +239.2% |
| Financing Cash Flow | -$854.1M | -822.1% |
| Free Cash Flow | $813.0M | +56.2% |
| -4.9% |
| EPS (Basic) | -$2.55 | -2.0% |
| EPS (Diluted) | -$2.55 | -2.0% |